ADHD Medication Shortages: The Real Impact

By Tim Williams · @AuDHD_Founder

You called the pharmacy on a Tuesday and they said they'd have it by Friday. You called Friday and they said probably next week, call back then. You called next week and a different person answered and they looked it up and said actually they don't know when they'll get it and maybe try other pharmacies. You called four other pharmacies and got four versions of the same answer.

Meanwhile your prescription is sitting in their system, filled but not dispensed, and your last pill was yesterday morning, and you have a full week of work ahead of you that requires exactly the level of sustained attention and executive function that your medication supports and that is, right now, not happening.

This isn't a minor inconvenience. For the people living it, ADHD medication shortages are a recurring crisis that most of the people causing them will never experience.

What's actually happening

The ADHD stimulant medication shortage that began in late 2022 and has continued in varying forms since is a supply chain problem rooted in DEA production quotas for Schedule II controlled substances, manufacturing concentration risk (a small number of facilities produce most generic amphetamine supply), and demand that increased significantly during and after the COVID-19 pandemic — both from genuine increased diagnosis rates and from telehealth prescribing expansion.

The FDA's drug shortage reporting system has listed amphetamine mixed salts (generic Adderall) and other stimulant formulations intermittently for years. The regulatory structure makes it extremely difficult to quickly increase supply, because manufacturers must apply to the DEA to increase their production quota, and that process takes time. Meanwhile patients run out.

The pharmacies can't solve it from their end. The prescribers can't solve it from their end. The patient is caught in the middle of a regulatory and manufacturing problem while trying to function in a workday that doesn't care about supply chains.

The Schedule II designation — designed to prevent misuse — also means that prescriptions for most stimulants cannot be called in or transferred. They require paper prescriptions in many states, in-person pickup, and strict refill windows. All of this creates maximum friction at exactly the moment when a patient is trying to manage a shortage.

Why this is specifically devastating

For someone without ADHD, a medication shortage is frustrating but manageable. For someone with ADHD who depends on stimulant medication to access their executive function, it's a functional impairment that hits multiple areas simultaneously: work performance, emotional regulation, task initiation, time management, and the ability to manage the very crisis they're in.

There's also the withdrawal piece. Stimulant medication discontinuation isn't physically dangerous in most cases, but it produces a rebound effect — increased fatigue, decreased motivation, increased emotional reactivity, brain fog, and often a return of symptoms significantly worse than baseline because the nervous system has calibrated around the medication. You don't just go back to unmedicated baseline. You often drop below it.

Asking someone with ADHD to manage a medication shortage — which requires sustained phone calls, tracking down information across multiple pharmacies, coordinating with their prescriber — while they're unmedicated is asking them to perform their highest-demand task with their lowest-functioning brain.

There's also the stigma layer. ADHD medications are heavily stigmatized as "study drugs," which contributes to political resistance to expanding supply, insufficient empathy from providers who minimize the impact of running out, and pressure on patients not to seem "too reliant" on their medication. Describing genuine functional impairment from going unmedicated gets read as drug-seeking, not as an accurate description of a chronic condition being improperly managed.

What actually helps

1. Build a buffer when you can.

If your medication access is reliable right now, talk to your prescriber about whether you can get a slightly extended supply — 90-day vs. 30-day, for example — that gives you more buffer when shortages hit. Some prescribers and insurance plans allow this. The time to make this request is when you're not in a shortage, not during one.

2. Establish relationships with multiple pharmacies.

Different pharmacy chains and independent pharmacies receive medication from different distributors. A shortage at one chain doesn't always mean a shortage everywhere. Call ahead before transferring prescriptions — ask specifically about current stock for your dose and formulation, not just "do you carry Adderall."

3. Know your prescriber's shortage protocol.

Ask your prescriber in advance: what do we do if my medication isn't available? Can we switch to a different formulation, a different medication, or an alternative dose? Having a backup plan established before you're in crisis takes one cognitive load item off an already-overwhelmed system.

4. On unmedicated days: lower the bar significantly.

The tasks that require sustained attention and executive function are not happening on the days you're out of medication. Accept this and restructure around it. Move body-based, low-cognitive-demand tasks to the front. Don't try to deliver the same output — you will fail, and the failure will compound the dysregulation. SHIFT's body-state check-ins help you recognize when you're running on a depleted system and adjust expectations accordingly.

5. Document the impact for your prescriber.

Keep notes on specifically how medication shortage affects your functioning. This is relevant to your ongoing care and potentially to any accommodations or documentation you need for work or school. It's also useful information for insurance appeals if you're fighting for access.

What doesn't help

• "Just push through it." Executive function isn't willpower. You can't push through a deficit in a neurochemical system the way you can push through fatigue. Telling yourself to try harder on an unmedicated ADHD day is not a strategy.
• Caffeine as a substitute. It's not a substitute. It's a mild stimulant that may take the edge off some symptoms and will not replicate what your actual medication does. It will also contribute to anxiety and sleep disruption, which makes the unmedicated days harder.
• Blaming yourself for the shortage. The supply problem is a regulatory and manufacturing failure. You didn't cause it by taking your medication correctly.
• Waiting too long to start the refill search. Call the pharmacy at ten days out, not two. The shortage process takes longer than you think it will, and starting early gives you more options.

The bigger picture

ADHD medication shortages are a systemic problem that disproportionately harms people with a condition that already makes systems-navigation harder. The people most impacted are the least equipped, in their unmedicated state, to navigate the systems that might help them. That's not irony. That's what inadequate infrastructure looks like from the inside.

What you can control: your buffer, your pharmacy network, your prescriber relationship, and your approach to unmedicated days. What you can't control: the DEA quota system, manufacturing capacity, and how long the shortage lasts. Focusing energy on the former and not catastrophizing the latter is the most practical path through.

For managing functioning on hard days generally — including the unmedicated ones — executive dysfunction: when your brain knows but won't start has strategies that work regardless of medication status. And SHIFT's regulation tools are built to support your nervous system when the usual props aren't available.